Article Details

AstraZeneca Ultomiris approved in Europe for treatment of adults with generalised myasthenia gravis

Retrieved on: 2022-09-25 06:32:34

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Ultomiris approved in Europe for treatment of adults with generalised myasthenia gravis. View article details on hiswai:

Excerpt

UK: AstraZeneca has recently announced that Ultomiris (ravulizumab) has been approved in Europe as an add-on to standard therapy for the treatment ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up